Clinuvel Pharmaceuticals Ltd (CUV) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.050x

Based on the latest financial reports, Clinuvel Pharmaceuticals Ltd (CUV) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$12.52 Million ≈ $8.86 Million USD) by net assets (AU$249.02 Million ≈ $176.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Clinuvel Pharmaceuticals Ltd balance sheet quality to measure how much of total assets are equity-financed.

Clinuvel Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Clinuvel Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CUV cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Clinuvel Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinuvel Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Xiamen Goldenhome Co Ltd SHG:603180	-0.071x
AMTD Digital Inc. NYSE:HKD	0.018x
Shandong Sinobioway Biomedicine Co Ltd SHE:002581	-0.043x
Tien Phong Securities Corp VN:ORS	-0.314x
Cogeco Inc. TO:CGO	0.046x
Sidetrade PA:ALBFR	0.086x
Tyro Payments Ltd AU:TYR	0.646x
Everyday Network SHE:300295	0.074x

Annual Cash Flow Conversion Efficiency for Clinuvel Pharmaceuticals Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Clinuvel Pharmaceuticals Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Clinuvel Pharmaceuticals Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$240.81 Million ≈ $170.39 Million	AU$41.10 Million ≈ $29.08 Million	0.171x	-6.50%
2024-06-30	AU$203.01 Million ≈ $143.64 Million	AU$37.05 Million ≈ $26.22 Million	0.183x	-18.59%
2023-06-30	AU$164.63 Million ≈ $116.49 Million	AU$36.91 Million ≈ $26.12 Million	0.224x	-29.40%
2022-06-30	AU$125.56 Million ≈ $88.84 Million	AU$39.87 Million ≈ $28.21 Million	0.318x	+62.78%
2021-06-30	AU$98.74 Million ≈ $69.86 Million	AU$19.26 Million ≈ $13.63 Million	0.195x	-0.91%
2020-06-30	AU$72.07 Million ≈ $50.99 Million	AU$14.19 Million ≈ $10.04 Million	0.197x	-39.00%
2019-06-30	AU$57.18 Million ≈ $40.46 Million	AU$18.46 Million ≈ $13.06 Million	0.323x	+8.80%
2018-06-30	AU$39.42 Million ≈ $27.89 Million	AU$11.69 Million ≈ $8.27 Million	0.297x	-23.88%
2017-06-30	AU$25.44 Million ≈ $18.00 Million	AU$9.92 Million ≈ $7.02 Million	0.390x	+238.00%
2016-06-30	AU$17.83 Million ≈ $12.62 Million	AU$-5.04 Million ≈ $-3.56 Million	-0.282x	+30.14%
2015-06-30	AU$11.21 Million ≈ $7.93 Million	AU$-4.53 Million ≈ $-3.21 Million	-0.404x	-29.70%
2014-06-30	AU$15.43 Million ≈ $10.92 Million	AU$-4.81 Million ≈ $-3.40 Million	-0.312x	+37.41%
2013-06-30	AU$13.84 Million ≈ $9.79 Million	AU$-6.89 Million ≈ $-4.88 Million	-0.498x	+32.24%
2012-06-30	AU$13.64 Million ≈ $9.65 Million	AU$-10.02 Million ≈ $-7.09 Million	-0.735x	-27.11%
2011-06-30	AU$16.41 Million ≈ $11.61 Million	AU$-9.49 Million ≈ $-6.71 Million	-0.578x	-29.67%
2010-06-30	AU$26.43 Million ≈ $18.70 Million	AU$-11.78 Million ≈ $-8.34 Million	-0.446x	-50.38%
2009-06-30	AU$37.05 Million ≈ $26.22 Million	AU$-10.99 Million ≈ $-7.77 Million	-0.296x	-113.93%
2008-06-30	AU$51.81 Million ≈ $36.66 Million	AU$-7.18 Million ≈ $-5.08 Million	-0.139x	-10.81%
2007-06-30	AU$65.39 Million ≈ $46.27 Million	AU$-8.18 Million ≈ $-5.79 Million	-0.125x	+84.66%
2006-06-30	AU$13.99 Million ≈ $9.90 Million	AU$-11.40 Million ≈ $-8.07 Million	-0.815x	+34.28%
2005-06-30	AU$7.45 Million ≈ $5.27 Million	AU$-9.25 Million ≈ $-6.54 Million	-1.240x	-82.98%
2004-06-30	AU$8.85 Million ≈ $6.27 Million	AU$-6.00 Million ≈ $-4.25 Million	-0.678x	-180.66%
2002-06-30	AU$10.31 Million ≈ $7.29 Million	AU$-2.49 Million ≈ $-1.76 Million	-0.242x	-531.42%
2001-06-30	AU$13.45 Million ≈ $9.52 Million	AU$-514.54K ≈ $-364.07K	-0.038x	--

About Clinuvel Pharmaceuticals Ltd

AU:CUV Australia Biotechnology

Market Cap

$332.90 Million

AU$470.49 Million AUD

Market Cap Rank

#14301 Global

#386 in Australia

Share Price

AU$9.33

Change (1 day)

+2.87%

52-Week Range

AU$8.72 - AU$13.70

All Time High

AU$44.55